| Literature DB >> 33550567 |
Isidoor O Bergfeld1,2, Eva Dijkstra1, Ilse Graat1, Pelle de Koning1, Bastijn J G van den Boom1,3, Tara Arbab1,3, Nienke Vulink1, Damiaan Denys1,2,3, Ingo Willuhn1,2,3, Roel J T Mocking4.
Abstract
It becomes increasingly clear that (non-)invasive neurostimulation is an effective treatment for obsessive-compulsive disorder (OCD). In this chapter we review the available evidence on techniques and targets, clinical results including a meta-analysis, mechanisms of action, and animal research. We focus on deep brain stimulation (DBS), but also cover non-invasive neurostimulation including transcranial magnetic stimulation (TMS). Data shows that most DBS studies target the ventral capsule/ventral striatum (VC/VS), with an overall 76% response rate in treatment-refractory OCD. Also TMS holds clinical promise. Increased insight in the normalizing effects of neurostimulation on cortico-striatal-thalamic-cortical (CSTC) loops - through neuroimaging and animal research - provides novel opportunities to further optimize treatment strategies. Advancing clinical implementation of neurostimulation techniques is essential to ameliorate the lives of the many treatment-refractory OCD patients.Entities:
Keywords: Deep brain stimulation; Neuromodulation; Transcranial magnetic stimulation; Treatment outcome; Working mechanisms
Year: 2021 PMID: 33550567 DOI: 10.1007/7854_2020_206
Source DB: PubMed Journal: Curr Top Behav Neurosci ISSN: 1866-3370